| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |